Liver Fibrosis Indices and Outcomes After Primary Intracerebral Hemorrhage

Author:

Parikh Neal S.1,Kamel Hooman1,Navi Babak B.1,Iadecola Costantino1,Merkler Alexander E.1,Jesudian Arun2,Dawson Jesse3,Falcone Guido J.4,Sheth Kevin N.4,Roh David J.5,Elkind Mitchell S.V.56,Hanley Daniel F.7,Ziai Wendy C.8,Murthy Santosh B.1,Hanley Daniel F.,Butcher Kenneth,Davis Stephen M.,Gregson Barbara,Lees Kennedy R.,Lyden Patrick D.,Mayer Stephan A.,Muir Keith,Steiner Thorsten

Affiliation:

1. From the Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology (N.S.P., H.K., B.B.N., C.I., A.E.M., S.B.M.), Weill Cornell Medicine, New York, NY

2. Division of Gastroenterology and Hepatology (A.J.), Weill Cornell Medicine, New York, NY

3. Department of Cerebrovascular Medicine, University of Glasgow, United Kingdom (J.D.)

4. Department of Neurology, Division of Neurocritical Care & Emergency Neurology, Yale University, New Haven, CT (G.J.F., K.N.S.)

5. Department of Neurology, Vagelos College of Physicians and Surgeons (D.J.R., M.S.V.E.), Columbia University, New York, NY

6. Department of Epidemiology, Mailman School of Public Health (M.S.V.E.), Columbia University, New York, NY

7. Brain Injury Outcomes Division (D.F.H.), Johns Hopkins University School of Medicine, Baltimore, MD.

8. Department of Neurology, Neurosurgery and Anesthesiology (W.C.Z.), Johns Hopkins University School of Medicine, Baltimore, MD.

Abstract

Background and Purpose— Cirrhosis—clinically overt, advanced liver disease—is associated with an increased risk of hemorrhagic stroke and poor stroke outcomes. We sought to investigate whether subclinical liver disease, specifically liver fibrosis, is associated with clinical and radiological outcomes in patients with primary intracerebral hemorrhage. Methods— We performed a retrospective cohort study using data from the Virtual International Stroke Trials Archive–Intracerebral Hemorrhage. We included adult patients with primary intracerebral hemorrhage presenting within 6 hours of symptom onset. We calculated 3 validated fibrosis indices—Aspartate Aminotransferase–Platelet Ratio Index, Fibrosis-4 score, and Nonalcoholic Fatty Liver Disease Fibrosis Score—and modeled them as continuous exposure variables. Primary outcomes were admission hematoma volume and hematoma expansion. Secondary outcomes were mortality, and the composite of major disability or death, at 90 days. We used linear and logistic regression models adjusted for previously established risk factors. Results— Among 432 patients with intracerebral hemorrhage, the mean Aspartate Aminotransferase–Platelet Ratio Index, Fibrosis-4, and Nonalcoholic Fatty Liver Disease Fibrosis Score values on admission reflected intermediate probabilities of fibrosis, whereas standard hepatic assays and coagulation parameters were largely normal. After adjusting for potential confounders, Aspartate Aminotransferase–Platelet Ratio Index was associated with hematoma volume (β, 0.20 [95% CI, 0.04–0.36]), hematoma expansion (odds ratio, 1.6 [95% CI, 1.1–2.3]), and mortality (odds ratio, 1.8 [95% CI, 1.1–2.7]). Fibrosis-4 was also associated with hematoma volume (β, 0.27 [95% CI, 0.07–0.47]), hematoma expansion (odds ratio, 1.9 [95% CI, 1.2–3.0]), and mortality (odds ratio, 2.0 [95% CI, 1.1–3.6]). Nonalcoholic Fatty Liver Disease Fibrosis Score was not associated with any outcome. Indices were not associated with the composite of major disability or death. Conclusions— In patients with largely normal liver chemistries, 2 liver fibrosis indices were associated with admission hematoma volume, hematoma expansion, and mortality after intracerebral hemorrhage.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3